Press Releases
-
24 Nov, 2025Spago Nanomedical announces outcome of oversubscribed rights issue
-
7 Nov, 2025The subscription period in Spago Nanomedical’s rights issue begins today
-
6 Nov, 2025Spago Nanomedical publishes information document in connection with forthcoming rights issue
-
29 Oct, 2025Spago Nanomedical resolves on a rights issue of approximately SEK 25 million to advance Tumorad
-
29 Oct, 2025Spago Nanomedical interim report January-September 2025